Ceapro Inc.
TSX VENTURE : CZO

Ceapro Inc.

June 15, 2015 08:00 ET

Ceapro Featured at the 12th International Congress on Engineering and Food (ICEF12)

Gilles Gagnon, M.Sc., MBA, Ceapro's President and CEO, Honorary Guest VIP Speaker at the ICEF opening ceremony

Bernhard Seifried, Ph.D., Senior Research Scientist and co-inventor of Ceapro's PGX Technology to present on June 17, 2015

EDMONTON, ALBERTA--(Marketwired - June 15, 2015) - Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced its featured participation in the 12th International Congress on Engineering and Food (ICEF12) being held June 14-18, 2015, at the Quebec City Convention Centre in Quebec City, Canada.

Ceapro's President and CEO, Gilles Gagnon, M.Sc., MBA, presented as the Honorary Guest VIP Speaker during the ICEF12 opening ceremony on Sunday, June 14, 2015. As part of his presentation, Mr. Gagnon discussed the current state of affairs and future opportunities for bioengineering and the bio-food industry.

Mr. Gagnon commented, "I am very honored to have been chose to present during the opening session of ICEF12. The congress is an integral part of the important bio-food industry at the heart of the Canadian expertise in bioengineering. Ceapro is proud to be included among the industry's most innovative colleagues and academia leaders. I look forward to the outcome of the many engaging and robust conversations related to future industry challenges that will take place this week as we all strive to advance the opportunities and vast potential of the rapidly evolving bio-food industry."

The Company's Senior Research Scientist, Bernhard Seifried, Ph.D., will make a presentation entitled, "PGX Technology: a platform technology for novel biopolymer ingredients," on Wednesday, June 17, 2015, at 12:00 p.m. EDT. Dr. Seifried is the co-inventor of Ceapro's novel platform processing technology called Pressurized Gas eXpanded Liquid Technology (PGX), a unique and disruptive technology with several key advantages over conventional drying and purification technologies that can be used to process biopolymers into high-value, nano-sized polymer structures and novel bio-nanocomposites.

About the 12th International Congress on Engineering and Food (ICEF12)

The goal of ICEF12 is to exchange new scientific knowledge of food engineering and to promote the interaction between professionals from academia, industry and government. The Congress will explore new paths for innovations in a rapidly changing food sector. ICEF12 will address questions related to the challenges that engineers are facing bringing science and creativity into food innovations. The Congress will be a vital opportunity to see what the future is for the bio-food industry, the impact of globalization and what place the local production and environmental issues should have in the world knowledge based bio-economy.

About Pressurized Gas eXpanded Liquid Technology (PGX)

PGX is a unique and disruptive technology with several key advantages over conventional drying and purification technologies that can be used to process biopolymers into high-value, nano-sized polymer structures and novel bio-nanocomposites. PGX is ideally suited for processing challenging high-molecular-weight, water-soluble biopolymers. It has the ability to make ultra-light, highly porous polymer structures on a continuous basis, which is not possible using today's conventional technologies. PGX was co-invented by Ceapro researcher Dr. Bernhard Seifried and University of Alberta professor, Dr. Feral Temelli.

About Ceapro Inc.

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and "active ingredients" from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company's website at www.ceapro.com.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information